Icon Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,145
Closed -$230K 305
2022
Q1
$230K Buy
+3,145
New +$211K 0.02% 299
2021
Q3
Sell
-3,226
Closed -$216K 342
2021
Q2
$216K Sell
3,226
-328
-9% -$21.4K 0.02% 335
2021
Q1
$224K Buy
+3,554
New +$221K 0.03% 310
2020
Q3
Sell
-8,273
Closed -$486K 261
2020
Q2
$486K Buy
+8,273
New +$495K 0.12% 130
2019
Q2
Sell
-60
Closed -$3K 242
2019
Q1
$3K Buy
+60
New +$2.99K ﹤0.01% 797
2018
Q3
Sell
-32
Closed -$2K 331
2018
Q2
$2K Buy
+32
New +$1.73K ﹤0.01% 794
2018
Q1
Sell
-32
Closed -$2K 320
2017
Q4
$2K Buy
+32
New +$2K ﹤0.01% 822

Other funds holding BMY

Icon Wealth Partners's BMY Position: Q2 2022 in Review

Icon Wealth Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 3,145 shares — an estimated $230K sold.

Icon Wealth Partners first reported a position in BMY in Q4 2017 and held it in 7 quarters. The position peaked at $486K in Q2 2020. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • Icon Wealth Partners reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
  • Icon Wealth Partners sold 3,145 Bristol-Myers Squibb shares in Q2 2022, an estimated $230K.
  • Icon Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 7 quarters.
  • Icon Wealth Partners's Bristol-Myers Squibb position peaked at $486K in Q2 2020.
  • 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Icon Wealth Partners's 13F filing for Q2 2022, filed 19 Jul 2022.